MAPT and Alzheimer disease: Under normal conditions, autophagy eliminates aberrant proteins and damaged organelles, while any disruption in this process can exacerbate amyloid and tau pathology, especially in AD. There is increasing focus on therapeutic strategies that promote autophagy, involving decreased calorie intake, autophagy-stimulating medications, and genetic therapy (Barmaki et al., 2023).